Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc.

Develops psychedelic-inspired medicines and therapies.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying Mind Medicine's stock with a target price of $23.78, indicating strong growth potential.

Above Average

Financial Health

Mind Medicine is performing well financially, showing strong cash flow and solid book value per share.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring MNMD

Employee Mental Health As A Benefit

Employee Mental Health As A Benefit

Discover companies transforming workplace wellness through innovative mental health solutions. These carefully selected stocks represent businesses helping corporations attract and retain talent by offering digital therapy, virtual counseling, and wellness technologies as employee benefits.

Published: June 17, 2025

Explore Basket
Mental Wellness Portfolio

Mental Wellness Portfolio

Invest in the future of mental healthcare. These carefully selected companies are leveraging technology to make mental health treatment more accessible, personalized, and effective, creating significant growth opportunities in an expanding market.

Published: June 17, 2025

Explore Basket
Mind & Spirit

Mind & Spirit

Invest in companies transforming mental healthcare through innovative treatments and technologies. These carefully selected stocks represent leaders in psychedelic therapeutics, telehealth platforms, and neurological treatments addressing the growing global demand for mental wellness solutions.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Pipeline-led growth

Clinical readouts and programme progress can drive valuation; outcomes vary and negative results are possible.

⚑

Regulatory catalysts

Trial data and regulator feedback are major catalysts that can move the stock, but approval pathways remain uncertain.

🌍

Market and funding

R&D intensity means possible future fundraisings; broader sentiment towards psychedelics also influences share performance.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions